Treatment

August 03, 2021

Latest Trends in Psoriatic Arthritis

Episode 138

Personalized medicine, the latest treatments such as IL-23, TK2 inhibitors, and a novel treatment in phase 2 clinical trials are just part of the latest news for psoriatic arthritis provided by rheumatologist Dr. Asim Khan with Voyage Healthcare in Maple Grove, MN.

Psound Bytes is supported by unrestricted educational grants from AbbVie, Amgen, Bristol Myers Squibb, Janssen, and Novartis.

Share
Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.